RA Capital Management, L.P. 13D and 13G filings for POINT Biopharma Global Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-26 5:29 pm Sale |
2022-09-26 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 0 0.000% |
-9,003,018 (Position Closed) |
Filing |
| 2022-09-16 4:29 pm Unchanged |
2022-09-14 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 9,003,018 8.650% |
0 (Unchanged) |
Filing |
| 2022-08-29 5:01 pm Purchase |
2022-08-25 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 9,003,018 9.900% |
147,000 (+1.66%) |
Filing |
| 2021-09-14 4:30 pm Unchanged |
2009-02-28 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 8,856,018 9.800% |
0 (Unchanged) |
Filing |
| 2021-07-20 4:31 pm Purchase |
2021-07-20 | 13G | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 8,856,018 9.800% |
8,856,018 (New Position) |
Filing |